According to Gelonghui on November 27, Goldman Sachs has upgraded the rating of JD Health to Buy, with a target price of HKD 33.50.
高盛：将京东健康评级上调至买进
Goldman Sachs: Upgrades jd health rating to Buy.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Hot News
Updated